Atlas Trials

Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Clinical trial NCT02198482 · TERMINATED

Trial details

NCT number
NCT02198482
Sponsor
University of Ulm
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome (MDS)
Start date
2016-02-01
Primary completion
2016-11-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.